Treace Medical Concepts, Inc. (NASDAQ: TMCI), a burgeoning player in the healthcare sector, operates within the medical devices industry, focusing on innovative solutions for bunion and midfoot deformities. The company’s..
LifeMD, Inc. (LFMD) is making waves in the healthcare sector with its innovative approach to telehealth services. As a direct-to-patient telehealth company, LifeMD connects consumers with healthcare professionals across the..
Niagen Bioscience, Inc. (NAGE) is gaining attention in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $1.09 billion, this U.S.-based company is carving out a..
Orthofix Medical Inc. (NASDAQ: OFIX) is carving a niche in the healthcare sector, particularly in the medical devices industry. With its strategic focus on innovative solutions in spine and orthopedics,..
Tilray Brands, Inc. (NASDAQ: TLRY) has emerged as a notable player in the healthcare sector, focusing on specialty and generic drug manufacturing. Despite the challenges inherent in the cannabis industry,..
Oculis Holding AG (NASDAQ: OCS), a Swiss biopharmaceutical company, is capturing investor attention with its strong growth potential in the healthcare sector. Specializing in cutting-edge ophthalmic treatments, Oculis is making..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a prominent player in the biotechnology industry, is capturing investor attention with its promising pipeline and remarkable potential upside. Headquartered in Cambridge, Massachusetts, this clinical-stage..
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company, is capturing investor attention with its significant 237% potential upside. Operating within the dynamic biotechnology sector, Xencor is at the forefront of..
Butterfly Network, Inc. (NASDAQ: BFLY), a key player in the healthcare sector specializing in medical devices, has recently captured investor attention with a staggering potential upside of 92.90%. With a..
Theravance Biopharma, Inc. (NASDAQ: TBPH), a company nestled within the dynamic biotechnology sector, presents an intriguing opportunity for investors with its significant potential upside. With a market capitalization of $531.01..
Individual investors eyeing opportunities in the biotechnology sector may find Enliven Therapeutics, Inc. (NASDAQ: ELVN) an intriguing prospect. With a market capitalization of $1.27 billion, this clinical-stage biopharmaceutical company is..
Owens & Minor, Inc. (NYSE: OMI) stands as a notable player in the healthcare sector, specifically within the medical distribution industry. Based in Glen Allen, Virginia, and with a rich..
Spyre Therapeutics, Inc. (SYRE) is capturing the attention of investors with its impressive potential upside of 257.43%, a figure that stands out in the volatile world of biotechnology investing. As..
Semler Scientific, Inc. (NASDAQ: SMLR), a healthcare-focused company based in Santa Clara, California, is making waves in the medical devices industry. With a market capitalization of $419.73 million, Semler is..
Cronos Group Inc. (NASDAQ: CRON), a cannabinoid company based in Stayner, Canada, is making notable strides in the burgeoning cannabis sector. With a market capitalization of $736.15 million, Cronos stands..
Enhabit, Inc. (NASDAQ: EHAB), a notable player in the healthcare sector, specifically within the medical care facilities industry, is carving out its niche in the United States by providing essential..
Neuropace, Inc. (NPCE), a key player in the medical devices industry, is making waves with its innovative technologies aimed at treating drug-resistant focal epilepsy. Headquartered in Mountain View, California, Neuropace..
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a beacon in the biotechnology sector, is capturing investor attention with its significant potential upside of 127.29%. Specializing in innovative therapies for central nervous..
REGENXBIO Inc. (NASDAQ: RGNX) is capturing the attention of investors with its promising position in the biotechnology sector, especially with a staggering potential upside of 270.48%. Let’s delve into the..
For investors with an eye on the healthcare sector, Vir Biotechnology, Inc. (NASDAQ: VIR) presents a compelling opportunity. Operating within the biotechnology industry, Vir Biotechnology is a clinical-stage biopharmaceutical company..
